Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 7321404, 7 pages
http://dx.doi.org/10.1155/2016/7321404
Review Article

Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes

1Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium
2Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Moscow 125315, Russia
3Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 121609, Russia

Received 19 September 2015; Accepted 9 December 2015

Academic Editor: Agnes L. Nishimura

Copyright © 2016 Ekaterina A. Ivanova and Alexander N. Orekhov. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Armulik, G. Genové, and C. Betsholtz, “Pericytes: developmental, physiological, and pathological perspectives, problems, and promises,” Developmental Cell, vol. 21, no. 2, pp. 193–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Dore-Duffy and K. Cleary, “Morphology and properties of pericytes,” Methods in Molecular Biology, vol. 686, pp. 49–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Ding, N. Song, and Y. Luo, “Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes,” Cancer Microenvironment, vol. 5, no. 3, pp. 225–236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Campagnolo, D. Cesselli, A. A.-H. Zen et al., “Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential,” Circulation, vol. 121, no. 15, pp. 1735–1745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Orekhov, Y. V. Bobryshev, and D. A. Chistiakov, “The complexity of cell composition of the intima of large arteries: Focus on pericyte-like cells,” Cardiovascular Research, vol. 103, no. 4, pp. 438–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Juchem, D. R. Weiss, B. Gansera, B. M. Kemkes, J. Mueller-Hoecker, and S. Nees, “Pericytes in the macrovascular intima: possible physiological and pathogenetic impact,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 3, pp. H754–H770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. M. Dulmovits and I. M. Herman, “Microvascular remodeling and wound healing: a role for pericytes,” The International Journal of Biochemistry & Cell Biology, vol. 44, no. 11, pp. 1800–1812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Campbell and G. R. Campbell, “Smooth muscle phenotypic modulation—a personal experience,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1784–1789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lacolley, V. Regnault, A. Nicoletti, Z. Li, and J.-B. Michel, “The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles,” Cardiovascular Research, vol. 95, no. 2, pp. 194–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W. J. Still and R. M. O'Neal, “Electron microscopic study of experimental atherosclerosis in the rat,” The American Journal of Pathology, vol. 40, pp. 21–35, 1962. View at Google Scholar
  13. L. Díaz-Flores, R. Gutiérrez, J. F. Madrid et al., “Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche,” Histology and Histopathology, vol. 24, no. 7, pp. 909–969, 2009. View at Google Scholar · View at Scopus
  14. C. G. M. van Dijk, F. E. Nieuweboer, J. Y. Pei et al., “The complex mural cell: pericyte function in health and disease,” International Journal of Cardiology, vol. 190, pp. 75–89, 2015. View at Publisher · View at Google Scholar
  15. R. J. Boado and W. M. Pardridge, “Differential expression of α-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells,” Journal of Neuroscience Research, vol. 39, no. 4, pp. 430–435, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hughes, T. Gardiner, P. Hu, L. Baxter, E. Rosinova, and T. Chan-Ling, “Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability,” Neurobiology of Aging, vol. 27, no. 12, pp. 1838–1847, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Crisan, M. Corselli, W. C. W. Chen, and B. Péault, “Perivascular cells for regenerative medicine,” Journal of Cellular and Molecular Medicine, vol. 16, no. 12, pp. 2851–2860, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Wanjare, S. Kusuma, and S. Gerecht, “Perivascular cells in blood vessel regeneration,” Biotechnology Journal, vol. 8, no. 4, pp. 434–447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Armulik, A. Abramsson, and C. Betsholtz, “Endothelial/pericyte interactions,” Circulation Research, vol. 97, no. 6, pp. 512–523, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Gökçinar-Yagci, D. Uçkan-Çetinkaya, and B. Çelebi-Saltik, “Pericytes: properties, functions and applications in tissue engineering,” Stem Cell Reviews and Reports, vol. 11, no. 4, pp. 549–559, 2015. View at Publisher · View at Google Scholar
  21. C. L. Maier, B. R. Shepherd, T. Yi, and J. S. Pober, “Explant outgrowth, propagation and characterization of human pericytes,” Microcirculation, vol. 17, no. 5, pp. 367–380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Cochain and A. Zernecke, “Macrophages and immune cells in atherosclerosis: recent advances and novel concepts,” Basic Research in Cardiology, vol. 110, article 34, 2015. View at Publisher · View at Google Scholar
  23. K. Bostrom, K. E. Watson, S. Horn, C. Wortham, I. M. Herman, and L. L. Demer, “Bone morphogenetic protein expression in human atherosclerotic lesions,” Journal of Clinical Investigation, vol. 91, no. 4, pp. 1800–1809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. E. R. Andreeva, M. D. Rekhter, Y. A. Romanov et al., “Stellate cells of aortic intima: II. Arborization of intimal cells in culture,” Tissue & Cell, vol. 24, no. 5, pp. 697–704, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. R. C. Nayak, A. B. Berman, K. L. George, G. S. Eisenbarth, and G. L. King, “A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes,” The Journal of Experimental Medicine, vol. 167, no. 3, pp. 1003–1015, 1988. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Psaltis and R. D. Simari, “Vascular wall progenitor cells in health and disease,” Circulation Research, vol. 1166, no. 8, pp. 1392–1412, 2015. View at Google Scholar
  27. D. P. Ramji and T. S. Davies, “Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets,” Cytokine & Growth Factor Reviews, vol. 26, no. 6, pp. 673–685, 2015. View at Publisher · View at Google Scholar
  28. E. R. Andreeva, V. N. Serebryakov, and A. N. Orekhov, “Gap junctional communication in primary culture of cells derived from human aortic intima,” Tissue & Cell, vol. 27, no. 5, pp. 591–597, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Ivanov, M. Philippova, J. Antropova et al., “Expression of cell adhesion molecule T-cadherin in the human vasculature,” Histochemistry and Cell Biology, vol. 115, no. 3, pp. 231–242, 2001. View at Google Scholar · View at Scopus
  30. T. Takeuchi and Y. Ohtsuki, “Recent progress in T-cadherin (CDH13, H-cadherin) research,” Histology and Histopathology, vol. 16, no. 4, pp. 1287–1293, 2001. View at Google Scholar · View at Scopus
  31. J. P. Kirton, N. J. Crofts, S. J. George, K. Brennan, and A. E. Canfield, “Wnt/β-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease?” Circulation Research, vol. 101, no. 6, pp. 581–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Farrington-Rock, N. J. Crofts, M. J. Doherty, B. A. Ashton, C. Griffin-Jones, and A. E. Canfield, “Chondrogenic and adipogenic potential of microvascular pericytes,” Circulation, vol. 110, no. 15, pp. 2226–2232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. B. K. Koo, “Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus,” Diabetes & Metabolism Journal, vol. 38, no. 1, pp. 32–34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. C. H. Ahn and S. H. Choi, “New drugs for treating dyslipidemia: beyond statins,” Diabetes & Metabolism Journal, vol. 39, no. 2, pp. 87–94, 2015. View at Publisher · View at Google Scholar
  35. I. Tabas, G. García-Cardeña, and G. K. Owens, “Recent insights into the cellular biology of atherosclerosis,” The Journal of Cell Biology, vol. 209, no. 1, pp. 13–22, 2015. View at Publisher · View at Google Scholar
  36. A. N. Orekhov, “Direct anti-atherosclerotic therapy; Development of natural anti-atherosclerotic drugs preventing cellular cholesterol retention,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5909–5928, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. E. Akopov, A. N. Orekhov, V. V. Tertov, K. A. Khashimov, E. S. Gabrielyan, and V. N. Smirnov, “Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta the effect of calcium antagonists,” Atherosclerosis, vol. 72, no. 2-3, pp. 245–248, 1988. View at Publisher · View at Google Scholar · View at Scopus
  38. B. J. McEwen, “The influence of herbal medicine on platelet function and coagulation: a narrative review,” Seminars in Thrombosis and Hemostasis, vol. 41, no. 3, pp. 300–314, 2015. View at Publisher · View at Google Scholar
  39. S. V. Rana, R. Pal, K. Vaiphei, S. K. Sharma, and R. P. Ola, “Garlic in health and disease,” Nutrition Research Reviews, vol. 24, no. 1, pp. 60–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Krishnaswamy, “Traditional Indian spices and their health significance,” Asia Pacific Journal of Clinical Nutrition, vol. 17, supplement 1, pp. 265–268, 2008. View at Google Scholar · View at Scopus
  41. J. Koscielny, D. Klüßendorf, R. Latza et al., “The antiatherosclerotic effect of Allium sativum,” Atherosclerosis, vol. 144, no. 1, pp. 237–249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Libby, A. Lichtman, and G. Hansson, “Immune effector mechanisms implicated in atherosclerosis: from mice to humans,” Immunity, vol. 38, no. 6, pp. 1092–1104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Machowska, J. J. Carrero, B. Lindholm, and P. Stenvinkel, “Therapeutics targeting persistent inflammation in chronic kidney disease,” Translational Research, vol. 167, no. 1, pp. 204–213, 2016. View at Publisher · View at Google Scholar
  45. T. Gorchakova, V. Myasoedova, I. Sobenin, and A. Orekhov, “Atherosclerosis prevention with the anti-inflammatory dietary supplement inflaminat,” Atherosclerosis Supplements, vol. 10, article 387, 2009. View at Google Scholar
  46. T. V. Gorchakova, I. V. Suprun, I. A. Sobenin et al., “Combined anti-inflammatory and anti-atherogenic activity of natural drug inflaminat—a perspective for long-term atherosclerosis prevention and treatment,” Atherosclerosis Supplements, vol. 8, article 224, 2007. View at Google Scholar
  47. R. L. Prentice, “Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke,” Seminars in Reproductive Medicine, vol. 32, no. 6, pp. 419–425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. V. B. Gencel, M. M. Benjamin, S. N. Bahou, and R. A. Khalil, “Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease,” Mini-Reviews in Medicinal Chemistry, vol. 12, no. 2, pp. 149–174, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Adlercreutz and W. Mazur, “Phyto-oestrogens and Western diseases,” Annals of Medicine, vol. 29, no. 2, pp. 95–120, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. V. A. Myasoedova and I. A. Sobenin, “Background, rationale and design of clinical study of the effect of isoflavonoid-rich botanicals on natural history of atherosclerosis in women,” Atherosclerosis Supplements, vol. 9, no. 1, article 171, 2008. View at Publisher · View at Google Scholar
  51. I. Sobenin, V. Myasoedova, and A. Orekhov, “Atherosclerosis prevention in postmenopausal women with the isoflavonoid-rich dietary supplement Karinat,” Journal of Clinical Lipidology, vol. 2, no. 5, pp. S26–S27, 2008. View at Publisher · View at Google Scholar